0.9448

31.04% -0.4252

After Hours: .94 -0.0048 -0.51%

Bioaffinity Technologies Inc (BIAF)

Overview News Price History Financials Discussions Forecast

Bioaffinity Technologies Inc stock is traded at $0.9448, with a volume of 3.20M. It is down -31.04% in the last 24 hours and down -49.74% over the past month. bioAffinity Technologies Inc develops noninvasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis informed by machine learning, a form of artificial intelligence (AI). Its first commercial diagnostic test, CyPath Lung, identifies and analyzes cell populations using flow cytometry, including cancer and cancer-related cells, that indicate a malignancy in the lung. It is developing its flow cytometry platform to address the need to identify patients who can benefit from new and emerging therapies for asthma and chronic obstructive pulmonary disease with noninvasive precision diagnostic tests. The company is organized in two operating segments, Diagnostic Research and Development and Laboratory Services.

Previous Close:

$1.37

Open:

$1.3

24h Volume:

3.20M

Relative Volume:

0.41

Market Cap:

$4.48M

Revenue:

$5.66M

Net Income/Loss:

$-15.88M

P/E Ratio:

-0.0835

EPS:

-11.3134

Net Cash Flow:

$-10.93M

1W Performance:

-37.43%

1M Performance:

-49.74%

6M Performance:

-31.54%

1Y Performance:

-87.99%

1-Day Range:

$0.94

$1.30

1-Week Range:

$0.94

$1.67

52-Week Range:

$0.693

$13.80

Bioaffinity Technologies Inc Stock (BIAF) Company Profile

Name

Bioaffinity Technologies Inc

Sector

Healthcare (1107)

Industry

Diagnostics & Research (50)

Phone

210-698-5334

Address

3300 NACOGDOCHES ROAD, SAN ANTONIO

Employee

Twitter

Next Earnings Date

2026-05-21

Latest SEC Filings

BIAF's Discussions on Twitter

Compare BIAF vs TMO, DHR, IDXX, A, WAT

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BIAF Bioaffinity Technologies Inc	0.9448	6.50M	5.66M	-15.88M	-10.93M	-11.31
TMO Thermo Fisher Scientific Inc	472.63	176.04B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	181.35	128.18B	24.78B	3.68B	5.29B	5.1743
IDXX Idexx Laboratories Inc	573.00	44.96B	4.45B	1.10B	1.06B	13.59
A Agilent Technologies Inc	128.34	36.88B	7.23B	1.41B	1.09B	4.979
WAT Waters Corp	360.54	35.13B	3.77B	449.25M	240.68M	7.8556

Bioaffinity Technologies Inc Stock (BIAF) Latest News

Jun 15, 2026

bioAffinity Technologies Warrant (BIAFW) Holds Steady at $0.16 as Trading Remains QuietRevenue Weighted - newsline.com

Jun 15, 2026

Jun 14, 2026

BIAF Q3 2025 Earnings: Wider-than-Expected Loss Misses EstimatesEarnings Miss Streak - newsline.com

Jun 14, 2026

Jun 13, 2026

BioAffinity Technologies Files to Offer 2.63M Shrs or Pre-Funded Warrants - Moomoo

Jun 13, 2026

Jun 12, 2026

BIAF News | BIOAFFINITY TECHNOLOGIES INC (NASDAQ:BIAF) - ChartMill

Jun 12, 2026

Bioaffinity TechnologiesOffers 2.63 Million Shares Of Common StockSEC Filing - TradingView

Jun 12, 2026

[S-1] bioAffinity Technologies, Inc. Files IPO Registration Statement - Stock Titan

Jun 12, 2026

BIAFW Holds Steady Amid Warrant Market Uncertainty: Support and Resistance in Tight RangeElliott Wave Entry - newsline.com

Jun 12, 2026

Jun 08, 2026

Multidisciplinary Physician Panel to Share Real-World Benefits of bioAffinity Technologies’ Noninvasive CyPath Lung Cancer Test in Upcoming Society for Advanced Bronchoscopy Webinar - BioSpace

Jun 02, 2026

bioAffinity Showcases CyPath Lung in Upcoming Clinical Webinar - TipRanks

Jun 02, 2026

bioAffinity webinar to showcase CyPath Lung's role in early-stage lung cancer detection - TradingView

Jun 02, 2026

bioAffinity Technologies (BIAF) spotlights CyPath Lung test in SAB lung cancer webinar - Stock Titan

Jun 02, 2026

May 30, 2026

BIAF Q3 2025 Earnings: Wider-than-Expected Loss as Pre-Revenue Biotech Continues DevelopmentManagement Guidance Update - thelegaladvocate.com

May 30, 2026

May 29, 2026

bioAffinity Technologies (BIAF) Edges Higher Amidst Support Test – Potential for BreakoutGap Down Bounce Plays - newsline.com

May 29, 2026

BIAFW Warrants Trade Flat Near Support Amidst Quiet Market ConditionsEntry Point Alerts - newsline.com

May 29, 2026

May 28, 2026

bioAffinity Technologies (BIAF) Holds Steady at $1.65 as Consolidation PersistsTechnical Analysis Picks - newsline.com

May 28, 2026

May 27, 2026

bioAffinity receives patent allowance in Mexico for lung test - Investing.com UK

May 27, 2026

bioAffinity Technologies Announces Notification of Mexico Patent Allowance Covering Novel Lung Cancer Detection Methods Using CyPath® Lung Technology - BioSpace

May 27, 2026

bioAffinity receives patent allowance in Mexico for lung test By Investing.com - Investing.com Nigeria

May 27, 2026

bioAffinity Technologies notifies Mexico patent allowance for CyPath® Lung flow cytometry method - TradingView

May 27, 2026

Mexico backs bioAffinity (NASDAQ: BIAF) patent on CyPath Lung test - Stock Titan

May 27, 2026

bioAffinity Gains Mexican Patent for CyPath Lung Diagnostic - TipRanks

May 27, 2026

May 26, 2026

bioAffinity Technologies (BIAF) News Flow - Moomoo

May 26, 2026

May 24, 2026

Number of shareholders of bioAffinity Technologies, Inc. – NASDAQ:BIAF - TradingView

May 24, 2026

May 22, 2026

BIAF Q3 2025 Earnings: EPS Misses Estimates Amid No Revenue, Stock DeclinesEarnings Miss Streak - newsline.com

May 22, 2026

May 21, 2026

What's Driving bioAffinity Technologies' Recent Surge - Kavout

May 21, 2026

May 20, 2026

Top AIAI (AIAI) Competitors 2026 - MarketBeat

May 20, 2026

May 15, 2026